Stryker Corporation (SYK) Financials
SYK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 39.4 billion | 20.2 billion |
2023-12-31 | 39.9 billion | 21.3 billion |
2023-09-30 | 38.0 billion | 20.1 billion |
2023-06-30 | 37.4 billion | 20.0 billion |
SYK Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 37.0 million | 87.0 million |
2023-12-31 | 1.4 billion | 40.0 million |
2023-09-30 | 902.0 million | 100000 |
2023-06-30 | 536.0 million | 200000 |
SYK Net Income
Date | Net Income |
---|---|
2024-03-31 | 788.0 million |
2023-12-31 | 1.1 billion |
2023-09-30 | 692.0 million |
2023-06-30 | 738.0 million |
SYK Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 2.4 billion | - | - |
2023-12-31 | 3.1 billion | - | - |
2023-09-30 | 1.9 billion | 10.4 billion | - |
2023-06-30 | 1.5 billion | 11.1 billion | - |
SYK Shares Outstanding
SYK Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 167.0 million | 368.0 million | 1.8 billion | - |
2023-12-31 | 145.0 million | 350.0 million | 1.9 billion | - |
2023-09-30 | 148.0 million | 353.0 million | 1.7 billion | - |
2023-06-30 | 152.0 million | 346.0 million | 1.7 billion | - |
SYK Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 5.2 billion | 2.1 billion |
2023-12-31 | 5.8 billion | 2.1 billion |
2023-09-30 | 4.9 billion | 1.8 billion |
2023-06-30 | 5.0 billion | 1.8 billion |
SYK
List: Champions
Price: $328.36
Dividend Yield: 0.98%
Forward Dividend Yield: 0.98%
Payout Ratio: 38.79%
Dividend Per Share: 3.20 USD
Earnings Per Share: 8.25 USD
P/E Ratio: 41.46
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 1.2 million
Ebitda: 881.0 millionMarket Capitalization: 125.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 32
DGR3: 8.47%
DGR5: 8.92%
DGR10: 9.87%
DGR20: 6.99%